ES2057121T3 - Antagonistas de los receptores alfa-adrenergicos. - Google Patents

Antagonistas de los receptores alfa-adrenergicos.

Info

Publication number
ES2057121T3
ES2057121T3 ES89305340T ES89305340T ES2057121T3 ES 2057121 T3 ES2057121 T3 ES 2057121T3 ES 89305340 T ES89305340 T ES 89305340T ES 89305340 T ES89305340 T ES 89305340T ES 2057121 T3 ES2057121 T3 ES 2057121T3
Authority
ES
Spain
Prior art keywords
alpha
antagonists
adrenergic receptors
adrenoreceptor antagonism
adrenoreceptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89305340T
Other languages
English (en)
Inventor
John Joseph Lafferty
Robert Michael Demarinis
Dinubhai Himatlal Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of ES2057121T3 publication Critical patent/ES2057121T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE EFIERE A ANTAGONISTAS ALFA - ADRENORECEPTORES QUE TIENEN LA FORMULA(I), UTILES PARA PRODUCIR ANTAGONISMO ALFA ADRENORECEPTOR; A COMPOSICIONES FARMACEUTICAS QUE LOS INCLUYEN Y A METODOS PARA SU EMPLEO A FIN DE INDUCIR ANTAGONISMO ALFA ADRENORECEPTOR EN MAMIFEROS.
ES89305340T 1988-06-01 1989-05-26 Antagonistas de los receptores alfa-adrenergicos. Expired - Lifetime ES2057121T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20100588A 1988-06-01 1988-06-01

Publications (1)

Publication Number Publication Date
ES2057121T3 true ES2057121T3 (es) 1994-10-16

Family

ID=22744089

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89305340T Expired - Lifetime ES2057121T3 (es) 1988-06-01 1989-05-26 Antagonistas de los receptores alfa-adrenergicos.

Country Status (19)

Country Link
EP (1) EP0344981B1 (es)
JP (1) JP2846019B2 (es)
KR (1) KR900701796A (es)
CN (1) CN1029404C (es)
AT (1) ATE109483T1 (es)
AU (1) AU629221B2 (es)
CA (1) CA1320954C (es)
DE (1) DE68917217T2 (es)
DK (1) DK286090A (es)
ES (1) ES2057121T3 (es)
FI (1) FI905922A0 (es)
HU (1) HU208695B (es)
IE (1) IE66886B1 (es)
MY (1) MY106292A (es)
PH (1) PH25534A (es)
PT (1) PT90720B (es)
WO (1) WO1989012053A1 (es)
ZA (1) ZA894099B (es)
ZW (1) ZW6989A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2824106B1 (en) 2012-03-06 2016-11-23 Takeda Pharmaceutical Company Limited Tricyclic compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856910A (en) * 1950-01-10 1974-12-24 Roussel Uclaf Novel thienobenzazepines as anti-depressants
US3649644A (en) * 1969-08-08 1972-03-14 Warner Lambert Co 1 2 3 4 4a 5 6 6a-octahydrobenzofuro (3 2-c)indoles
BE795451A (fr) * 1972-02-23 1973-08-16 Pfizer Agents hypoglycemiants aza indoliques tricycliques
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
JPS57144286A (en) * 1981-03-02 1982-09-06 Takeda Chem Ind Ltd Azepinoindole derivative and its preparation
US4833244A (en) * 1985-04-22 1989-05-23 Hoechst-Rouseel Pharmaceuticals Inc. Ethanobenzazepines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4769368A (en) * 1986-02-10 1988-09-06 Smithkline Beckman Corporation 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines
DE3630539A1 (de) * 1986-09-08 1988-03-10 Madaus & Co Dr Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten

Also Published As

Publication number Publication date
JPH03504604A (ja) 1991-10-09
JP2846019B2 (ja) 1999-01-13
IE891740L (en) 1989-12-01
HUT58742A (en) 1992-03-30
KR900701796A (ko) 1990-12-04
CN1038100A (zh) 1989-12-20
DE68917217D1 (de) 1994-09-08
FI905922A7 (fi) 1990-11-30
CN1029404C (zh) 1995-08-02
EP0344981A2 (en) 1989-12-06
DK286090D0 (da) 1990-11-30
FI905922A0 (fi) 1990-11-30
PH25534A (en) 1991-07-24
DK286090A (da) 1990-11-30
ATE109483T1 (de) 1994-08-15
PT90720B (pt) 1994-10-31
EP0344981A3 (en) 1991-05-15
DE68917217T2 (de) 1994-12-01
HU208695B (en) 1993-12-28
WO1989012053A1 (en) 1989-12-14
ZW6989A1 (en) 1989-08-30
EP0344981B1 (en) 1994-08-03
MY106292A (en) 1995-04-29
PT90720A (pt) 1989-12-29
ZA894099B (en) 1990-06-27
AU629221B2 (en) 1992-10-01
HU893309D0 (en) 1991-05-28
AU3741589A (en) 1990-01-05
CA1320954C (en) 1993-08-03
IE66886B1 (en) 1996-02-07

Similar Documents

Publication Publication Date Title
ES2131830T3 (es) Benzamidinas sustituidas, su preparacion y uso como medicamentos.
ECSP941135A (es) Antagonistas triciclicos de vasopresina de benzacepina
AR029605A1 (es) DERIVADOS DE DIFENILUREA SUBSTITUIDOS CON SULFONAMIDA , COMPOSICIoN FARMACEUTICA , USO DE LOS MISMOS PARA LA MANUFACTURA DE UN MEDICAMENTO uTILES COMO ANTAGONISTA DE RECEPTORES DE IL-8, COMPUESTOS, INTERMEDIARIOS, Y MÉTODOS DE CONVERSIoN DE COMPUESTOS
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
ES2178676T3 (es) Compuestos de pirimidina substituidos y su empleo.
AR062931A2 (es) Compuestos que se enlazan a y activan un receptor de la trombopoyetina , composicones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2054716T3 (es) Bis-naftalimidas, su obtencion y empleo.
ES2175741T3 (es) Nuevos derivados del acido sulfinico, su procedimiento de preparacion y su utilizacion.
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
ES2061452T3 (es) Nuevas hetrazepinas y procedimiento para su preparacion.
ES2086313T3 (es) Nuevos derivados de xantina con efecto antagonista de adenosina.
ES2043625T3 (es) Derivados de acido ariloxicarboxilico, su preparacion y empleo.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
AR002268A1 (es) Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas.
ES2062239T3 (es) Diamidas de acidos pirimidin-4,6-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos.
ES2065324T3 (es) N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos.
ES2053429T3 (es) El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica.
ES2119326T3 (es) Compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
CR6398A (es) Antagonistas de 5ht1 para terapia antidepresiva
ES2147453T3 (es) Antagonistas de adenosina, procedimiento para su preparacion y su uso como medicamentos.
DK2886A (da) Dopamin-beta-hydroxylaseinhibitorer
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 344981

Country of ref document: ES